POWER PAD 2 is a prospective, single-arm, multicenter, non-randomized clinical study designed to demonstrate the safety and effectiveness of the Amplitude Vascular Systems (AVS) Pulse Intravascular Lithotripsy™ (Pulse IVL™) System for treatment of calcified (moderate to severe), stenotic, superficial femoral and popliteal arteries in patients with peripheral arterial disease.
POWER PAD 2 is a prospective, single-arm, multicenter, non-randomized clinical study designed to demonstrate the safety and effectiveness of the Amplitude Vascular Systems (AVS) Pulse Intravascular Lithotripsy™ (Pulse IVL™) System for treatment of calcified (moderate to severe), stenotic, superficial femoral and popliteal arteries in patients with peripheral arterial disease.
Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial
-
Midwest Cardiovascular Research Foundation, Davenport, Iowa, United States, 52802
Columbia University and New York Presbyterian Hospital (NYPH), New York, New York, United States, 10032
OhioHealth, Columbus, Ohio, United States, 43214
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Amplitude Vascular Systems, Inc.,
Christopher Metzger, MD, PRINCIPAL_INVESTIGATOR, Ohio Health
2026-03